Next Science Limited
OTC: NXSCF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Matthew Franco Myntti
- Headquarters
- Sydney, Australia
- IPO year
- 2021
- Market cap
- $292.6K
- Website
- https://www.nextscience.com
Loading NXSCF…
Loading profile data…Frequently asked questions about NXSCF
What does Next Science Limited (NXSCF) do?
Next Science Limited operates as a medical technology firm, dedicated to the research, development, and commercialization of innovative solutions aimed at mitigating the detrimental effects of biofilms on human health. The company serves markets in both the United States and Australia, building its product portfolio on its proprietary Xbio Techn...
Where does NXSCF trade?
Next Science Limited (NXSCF) trades on the Other OTC.
What sector is NXSCF in?
Next Science Limited (NXSCF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Next Science Limited?
Matthew Franco Myntti is the chief executive officer of Next Science Limited (NXSCF).
Where is Next Science Limited headquartered?
Next Science Limited is headquartered in Australia.
Does NXSCF pay a dividend?
Yes — Next Science Limited (NXSCF) paid a trailing twelve-month dividend of USD 0.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did NXSCF go public?
Next Science Limited (NXSCF) completed its initial public offering in 2021.